Cargando…

Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit

We decreased antimicrobial drug consumption in an intensive care unit in Lebanon by changing to colistin monotherapy for extensively drug-resistant Acinetobacter baumanii infections. We saw a 78% decrease of A. baumanii in sputum and near-elimination of bla(oxa-23)-carrying sequence type 2 clone ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chamieh, Amanda, Nawfal, Tania Dagher, Ballouz, Tala, Afif, Claude, Juvelekian, George, Hlais, Sani, Rolain, Jean-Marc, Azar, Eid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2019
Materias:	Dispatch
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759246/ https://www.ncbi.nlm.nih.gov/pubmed/31538925 http://dx.doi.org/10.3201/eid2510.181626

Ejemplares similares

Risk Factors, Clinical Presentation, and Outcome of Acinetobacter baumannii Bacteremia
por: Ballouz, Tala, et al.
Publicado: (2017)

An outbreak of Acinetobacter baumanii in an ICU: effectiveness of an extensive infection control program
por: Bonizzoli, M, et al.
Publicado: (2006)

Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon
por: Nawfal Dagher, Tania, et al.
Publicado: (2019)

846. Trends in Acinetobacter baumanii Antibiotic Resistance Rates
por: Caffrey, Aisling, et al.
Publicado: (2020)

1610. Epidemiology and Treatment Heterogeneity in Acinetobacter baumanii Infections
por: Caffrey, Aisling, et al.
Publicado: (2020)

Successful treatment of multicompartmental cerebral ventriculitis caused by Acinetobacter baumanii
por: Mahoney, Dom, et al.
Publicado: (2017)

S33.1 Multidrug-resistant Acinetobacter baumanii and Pseudomonas aeruginosa
Publicado: (2005)

244. The Double-Edged Sword of Cost Effectiveness in Evaluating Antimicrobial Stewardship Interventions
por: Zmerli, Omar, et al.
Publicado: (2020)

A challenging modified measles outbreak in vaccinated healthcare providers
por: Zmerli, Omar, et al.
Publicado: (2020)

Management of an outbreak of multiresistant Acinetobacter baumanii infection in a surgical intensive care unit
por: Lewejohann, J, et al.
Publicado: (2007)

The antibiotic resistance proteome of Acinetobacter baumanii MDR isolate MMC#4
por: Marshall, Dana, et al.
Publicado: (2012)

Use of daptomycin and vancomycin in blood stream infections with PDR Acinetobacter Baumanii
por: Alexandropoulos, P, et al.
Publicado: (2015)

Minocycline: The second important antimicrobial in multidrug-resistant Acinetobacter baumanii infections
por: Nair, Abhijit S.
Publicado: (2018)

Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath
por: Chamieh, Amanda, et al.
Publicado: (2021)

Clinical experiment with the use of colistin for the treatment of multiresistant Acinetobacter baumanii nosocomial infection
por: Safi, L, et al.
Publicado: (2009)

Ozone fumigation successfully controlled and eradicated multidrug-resistant Acinetobacter baumanii from an intensive care unit
por: Stümpfle, R, et al.
Publicado: (2010)

Intrathecal (intraventricular) polymyxin B in the treatment of patients with meningoencephalitis by Acinetobacter baumanii and Pseudomonas aeruginosa
por: Macedo, SK, et al.
Publicado: (2011)

Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
por: Di Bonito, Marianna, et al.
Publicado: (2012)

Draft Genome Sequences of Two Multidrug-Resistant Sequence Type 405 Escherichia coli Isolates without Clinical Infection
por: Chamieh, Amanda, et al.
Publicado: (2021)

Draft Genome Sequence of an NDM-1-Producing Sequence Type 101 (ST101) Klebsiella pneumoniae Strain, Marseille-Q1949
por: Chamieh, Amanda, et al.
Publicado: (2021)

Next-gen sequencing of multi-drug resistant Acinetobacter baumanii at Nashville General Hospital at Meharry
por: Dent, Leon, et al.
Publicado: (2011)

Bloodstream infection with Acinetobacter baumanii in a Plasmodium falciparum positive infant: a case report
por: Akenten, Charity Wiafe, et al.
Publicado: (2021)

Acinetobacter baumannii in Human Body Louse
por: La Scola, Bernard, et al.
Publicado: (2004)

Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India
por: Taneja, Neelam, et al.
Publicado: (2011)

Association of Single Nucleotide Polymorphisms in Toll-like Receptors with Acinetobacter baumanii Infectionin a Chinese Population
por: HE, Lei, et al.
Publicado: (2016)

Fatal Acinetobacter baumanii Necrotizing Fasciitis following Open Reduction Internal Fixation in a Polytrauma Patient
por: Nehme, Alexandre, et al.
Publicado: (2018)

Multidrug-Resistant Acinetobacter baumannii in Veterinary Clinics, Germany
por: Zordan, Sabrina, et al.
Publicado: (2011)

VIM-1 Metallo-β-lactamase in Acinetobacter baumannii
por: Tsakris, Athanassios, et al.
Publicado: (2006)

Toward Cholera Elimination, Haiti
por: Rebaudet, Stanislas, et al.
Publicado: (2021)

Wealth Inequality and Tuberculosis Elimination in Europe
por: Suk, Jonathan E., et al.
Publicado: (2009)

Eliminating Trachoma in Areas with Limited Disease
por: Gaynor, Bruce D., et al.
Publicado: (2003)

Multidrug-Resistant Acinetobacter baumannii Harboring OXA-24 Carbapenemase, Spain
por: Acosta, Joshi, et al.
Publicado: (2011)

Imported Measles and Implications for Its Elimination in Taiwan
por: Cheng, Wen-Yueh, et al.
Publicado: (2011)

Extensive Dermatophytosis Caused by Terbinafine-Resistant Trichophyton indotineae, France
por: Jabet, Arnaud, et al.
Publicado: (2022)

Severe Community-Acquired Bloodstream Infection with Acinetobacter ursingii in Person who Injects Drugs
por: Salzer, Helmut J.F., et al.
Publicado: (2016)

Distribution of Carbapenemase Genes among Carbapenem-Non-Susceptible Acinetobacter baumanii Blood Isolates in Indonesia: A Multicenter Study
por: Anggraini, Dewi, et al.
Publicado: (2022)

Emergence of plasmid-encoded VIM-2–producing Pseudomonas aeruginosa isolated from clinical samples in Lebanon
por: Nawfal Dagher, T., et al.
Publicado: (2019)

VIM- and IMP-Type Metallo-β-lactamase–Producing Pseudomonas spp. and Acinetobacter spp. in Korean Hospitals
por: Lee, Kyungwon, et al.
Publicado: (2003)

Extensively Drug-Resistant Tuberculosis, Pakistan
por: Hasan, Rumina, et al.
Publicado: (2010)

Hepatitis C Virus Elimination Program among Prison Inmates, Israel
por: Eisen, Lihi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tjareit7g7q93gsms84vo3ppq4